Colorectal Cancer News and reporting on colorectal cancer. Liquid Biopsy-Guided EGFR Rechallenge Therapy Shows Benefit for Colorectal Cancer Patients The first interventional trial to use ctDNA to recruit eligible patients for this treatment showed 30 percent observable responses and more than 60 percent disease control. Oncocyte, Italian Foundation to Investigate DetermaIO in Colorectal Cancer The Italian research group will evaluate the ability of Oncocyte's gene expression assay in samples from immunotherapy trials for advanced colorectal cancer patients. AACR Presentations Highlight Power of Large Tumor Atlases in Studies of Cancer Progression Premium The talks focused on studies stemming from the Cancer Moonshot initiative's Human Tumor Atlas Network project, which is readying its first data release. Colorectal Cancer Relapse Can Be Predicted by ctDNA Clearance, Study Shows Researchers found patients who had remaining ctDNA after surgery and adjuvant chemo were 12 times more likely to experience recurrence than ctDNA-negative patients. Guardant MRD Test Performs Well in Small Study as Tissue-Informed Debate Takes Shape Premium The data, while limited, indicate that the firm's blood-only assay may be able to match the performance of existing commercial tissue-informed competitors. May 7, 2021 Indivumed, Oslo University Hospital Partner on AI-Driven Colorectal Cancer Research Apr 30, 2021 Aiming to Cut Unnecessary Surgeries, City of Hope Team to Commercialize CRC Metastasis Dx Signature Premium Apr 20, 2021 Biocartis Files FDA Submission for Microsatellite Instability Test in Colorectal Cancer Apr 1, 2021 Guardant Health Receives New York State Approval for Guardant Reveal MRD Test Mar 31, 2021 Startup MiCareo Targets Rare Cell Isolation Market With Flow Displacement Instrument Premium Mar 27, 2021 Liquid Biopsy MRD Detection Eyed as Decision Tool for Oligometastatic Colorectal Cancer Patients Premium Mar 25, 2021 Epigenomics Reports 24 Percent Drop in 2020 Revenues, Seeks Sale After Negative Coverage Decision Mar 23, 2021 CellMax Life, Sebela Pharmaceuticals Sign Commercial Agreement for Colorectal Cancer Dx Test Mar 15, 2021 Dana Farber Team Applies PCR Method to ID Microsatellite Instability in Tumor-Derived Samples Premium Mar 12, 2021 GeneFirst Aims to Prove Clinical Feasibility for ATOM-Seq Colorectal Cancer Detection Test Premium Mar 10, 2021 Datar Cancer Genetics Obtains CE Mark for Liquid Biopsy Cancer Test Feb 26, 2021 Natera Launches Tumor Genomic Profiling Assay, Expects Reproductive Health to Break Even This Year Premium Feb 26, 2021 Guardant Health Begins First Foray Into Early-Stage Cancer With Commercial MRD Test Launch Premium Feb 25, 2021 Natera Revenues Grow 35 Percent in Q4 Feb 19, 2021 Researchers Aim to Improve Lynch Syndrome Testing With Genetic-Epigenetic Combination Method Premium Feb 18, 2021 Cancer Screening Test Developer New Horizon Health Goes Public in Hong Kong Feb 17, 2021 Exact Sciences Sketches Out Strategy for End-to-End Cancer Testing With Ashion Acquisition Premium Feb 16, 2021 Exact Sciences Q4 Revenues up 58 Percent; Company to Acquire Ashion Analytics From TGen Feb 9, 2021 Spanish Cancer Company Universal Dx to Commercialize Methylation Method for Lung Cancer Detection Premium Jan 20, 2021 CMS Finalizes Blood-Based Colon Cancer Screening NCD with Non-Coverage for Epi ProColon Load More Breaking News Roche Receives FDA EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.